Clinical Trial Update: A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating dexmedetomidine to prevent delirium after hip fracture repair has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Precedex (dexmedetomidine) (dexmedetomidine)

Snippet

Sponsor: Hospira, now a wholly owned subsidiary of Pfizer | Conditions: Delirium | Phase 3 | Status: TERMINATED